Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP [Phase 4]
Phase 4 trial update on glycyrrhetinic acid combined with dexamethasone for newly diagnosed immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP) [Phase 3]
A Phase 3 clinical trial evaluating LIV-GAMMA SN Inj. for efficacy and safety in adults with immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) [Phase 2]
Open-label Phase 2 safety study for lusutrombopag in adults with chronic immune thrombocytopenia (ITP) has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study of lusutrombopag (S-888711) in adults with immune thrombocytopenia (ITP) was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating tacrolimus with high-dose dexamethasone as first-line therapy for adult immune thrombocytopenia; status currently u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial investigating low-dose rituximab plus ATRA for steroid-resistant or relapsed immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: A Study of ATRA in the Treatment of ITP [Phase 2]
Phase 2 clinical trial update on all-trans retinoic acid (ATRA) for immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia [Phase 3]
A pilot, randomized, double-blind study comparing oseltamivir to placebo for immune thrombocytopenia in a Phase 3 setting; status currently …
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia
A clinical trial update investigating eltrombopag in combination with recombinant human thrombopoietin for corticosteroid-resistant or relap…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating romiplostim, rituximab, and dexamethasone as frontline treatment for immune thrombocytopenia and thrombotic thrombo…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Combination of Danazole With Berberine in the Treatment of ITP [Phase 2]
A Phase 2 trial evaluating the combination of Danazol with Berberine for corticosteroid-resistant or relapsed immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP [Phase 4]
Phase 4 randomized study comparing vitamin D added to high-dose dexamethasone versus high-dose dexamethasone alone for immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) [Phase 2]
Phase 2 trial comparing eltrombopag plus rhTPO to eltrombopag alone for immune thrombocytopenia during COVID-19.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults [Phase 4]
A Phase 4 clinical trial comparing eltrombopag alone versus eltrombopag combined with rituximab in adults with primary immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial exploring the combination of terbutaline and danazol for steroid-resistant/relapse immune thrombocytopenia. Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Immunomodulation With Romiplostim in Young Adults With ITP [Phase 4]
Phase 4 trial update on immunomodulation with romiplostim in young adults with immune thrombocytopenia has been completed.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP [Phase 2]
Phase 2 trial evaluating high-dose dexamethasone plus acetylcysteine for newly diagnosed immune thrombocytopenia is in early stages with sta…
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy [Phase 3]
Phase 3 multicenter trial evaluating recombinant human thrombopoietin for managing immune thrombocytopenia in pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Caffeic Acid Combining High-dose Dexamethasone in Management of ITP [Phase 4]
Phase 4 clinical trial update on using caffeic acid in combination with high-dose dexamethasone for immune thrombocytopenia (ITP) completed.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia [Phase 2]
Phase II trial investigating romiplostim with danazol for patients with eltrombopag-resistant immune thrombocytopenia is ongoing (Phase II, …
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Open Label Extension Study of AMG 531 in Japanese Subjects With ITP [Phase 2, Phase 3]
Open-label extension study of AMG 531 in Japanese subjects with immune thrombocytopenic purpura (ITP) completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura [Phase 4]
A Phase 4 clinical trial evaluating whether eradication of Helicobacter pylori affects outcomes in children with chronic immune thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of rhTPO and eltrombopag in patients with primary immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Eltrombopag in Chronic ITP [Phase 4]
Phase 4 clinical trial update for eltrombopag in chronic immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 clinical trial evaluating different rhTPO regimens for efficacy and safety in patients with primary immune thrombocytopenia (ITP) ha…